Practitioner product
Summary
- Features Palmitoylethanolamide (PEA) from Levagen+TM a fatty acid amide with quercetin dihydrate
- Utilises LipiSperse® technology to enhance water solubility and absorption
- May help to reduce mild nerve pain and neuralgia
- No artificial colours, flavours or preservatives
- No added nuts, soy or dairy
Dosage
- 1 - 2 capsules daily
Warnings
- Adults only
- Not to be used for more than 21 consecutive days
- May interact with other prescription analgesic medicines, consult your healthcare practitioner before use
- Always read the label
- Dietary supplements should not replace a balanced diet
- If symptoms persist, worsen or change unexpectedly, consult your healthcare professional
Formula
| Ingredient |
1 capsule
|
|---|---|
| Levagen™ with LipiSperse® Palmitoylethanolamide (PEA) | 300 mg |
| Quercetin dihydrate | 30 mg |
Downloads
This product is listed with the TGA - AustL 374580. The TGA publishes product info, including excipients under the "Other ingredients" subheading (not typically listed on the product label). Download the TGA public summary below. Learn more about excipients
